Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111269134B reveals a green magnetic nanocatalyst route for phenylglycine, offering high purity and simplified recovery for reliable pharmaceutical intermediate supply chains.
Patent CN114214651B reveals electrocatalytic synthesis for high-purity thiocyanatosulfoxide ylide. Green process offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN103288737B details high-yield iminostilbene synthesis. Reduces steps and pollution for reliable pharmaceutical intermediates supplier cost efficiency.
Patent CN107868040A reveals a novel Fe-Mn-Mo-TiO catalyst route for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN110878104A reveals a safer two-step route for chiral phosphine ligands. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN110698360A details a green visible-light method for amide synthesis. Discover cost-effective, metal-free manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN118359593A reveals a Ru/Cu bimetallic method for stereodivergent delta-lactone synthesis, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN110172022A reveals a green organophosphorus catalyzed difluoroalkylation method. Discover cost-effective solutions for fluorine material manufacturing and supply chain optimization.
Patent CN116159601A reveals a novel eribulin intermediate route reducing chromium usage and boosting total yield to 33.7%, offering significant cost and supply chain advantages.
Patent CN103910723A reveals a novel visible light catalytic method for indoloquinoline synthesis using cheap metal salts and air oxygen, offering significant cost and supply chain advantages.
Patent CN113603653A reveals a visible light-promoted method for seleno-oxazolidine-2,4-dione. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable green chemistry.
Novel N-oxide route reduces cost and safety risks for high-purity pharmaceutical intermediates manufacturing supply chain reliability and operational efficiency significantly for buyers.
Patent CN114716356B reveals green rhodium catalysis for isothiocyanates. Offers high purity, mild conditions, and supply chain stability for pharma intermediates.
Patent CN106699628A reveals efficient levulinic acid conversion. Lower temperature, high yield pyrrolidone synthesis for reliable supply chain.
Patent CN101607896B reveals a green synthesis route for DA-TMHQ using acidic ionic liquids, offering superior catalyst recyclability and reduced environmental impact for vitamin E production.
Patent CN103415501A details stable iodoarene derivatives for high-ee spirolactone production. Enables cost reduction in pharma intermediate manufacturing with scalable catalytic routes.
Patent CN103087039A details a novel room-temperature synthesis of poly-substituted benzo[1,3]dioxolanes using ethyl 4-chloroacetoacetate and 1,2-allenones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel visible-light method replaces expensive silver reagents, offering high-yield, scalable production for pharmaceutical intermediates.
Patent CN115745823A details a novel asymmetric synthesis for high-purity chloramphenicol intermediates, offering cost reduction and scalable manufacturing solutions.
Advanced synthesis of 2-(3,3,3-trifluoropropylthio)adenosine via patent CN108033983B. Offers high yield, safety, and cost reduction in API manufacturing.